Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2004-11-30
pubmed:abstractText
To investigate the possible existence of an antiapoptotic cross-talk between HER-2 and antiapoptotic Bcl-2 family members.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrans, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, Antisense, http://linkedlifedata.com/resource/pubmed/chemical/PD 98059, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein, http://linkedlifedata.com/resource/pubmed/chemical/ethyl..., http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7747-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15570009-Antibodies, Monoclonal, pubmed-meshheading:15570009-Antibodies, Monoclonal, Humanized, pubmed-meshheading:15570009-Antineoplastic Agents, pubmed-meshheading:15570009-Apoptosis, pubmed-meshheading:15570009-Benzopyrans, pubmed-meshheading:15570009-Blotting, Western, pubmed-meshheading:15570009-Breast Neoplasms, pubmed-meshheading:15570009-Cell Line, Tumor, pubmed-meshheading:15570009-Down-Regulation, pubmed-meshheading:15570009-Enzyme Inhibitors, pubmed-meshheading:15570009-Flavonoids, pubmed-meshheading:15570009-Flow Cytometry, pubmed-meshheading:15570009-Humans, pubmed-meshheading:15570009-Immunohistochemistry, pubmed-meshheading:15570009-In Situ Hybridization, Fluorescence, pubmed-meshheading:15570009-Nitriles, pubmed-meshheading:15570009-Oligonucleotides, Antisense, pubmed-meshheading:15570009-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:15570009-RNA, Messenger, pubmed-meshheading:15570009-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15570009-Time Factors, pubmed-meshheading:15570009-Transfection, pubmed-meshheading:15570009-Up-Regulation, pubmed-meshheading:15570009-bcl-X Protein
pubmed:year
2004
pubmed:articleTitle
Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.
pubmed:affiliation
Division of Medical Oncology A, Laboratory of Experimental Preclinical Chemotherapy, Laboratory B, Division of Pathology, and Division of Clinical Pathology, Regina Elena National Cancer Institute, Rome, Italy. milella@ifo.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't